The Wegovy pill’s ‘surprise miss’ is one reason Novo Nordisk’s stock is down
The Danish drugmaker also revealed an improved outlook for the year.
Original Source
Read the full article at Marketwatch →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.